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ABSTRACT
Individual characteristics of human nature (e.g. introversion, extroversion, mood, activity, adaptability, aggressiveness, social ability, 
anxiety) do not need to be primarily innate. They can be determined by the action of various influences and their interactions on 
functional development of the brain. There is ample epidemiological and experimental evidence that chemical and/or physical factors 
acting during sensitive time windows of the brain development can cause mental, behavioral, emotional and/or cognitive disorders. 
Environmental pollutants, addictive substances, drugs, malnutrition, excessive stress and/or hypoxia-ischemia were reported to induce 
functional maldevelopment of the brain with consequent neurobehavioral disorders. The article provides review on most significant 
neurobehavioral manifestations of developmental impairment of the brain during prenatal, perinatal and early postnatal period. The 
most known adverse factors causing developmental neurobehavioral dysfunctions in humans as well as in experimental animals are 
discussed. 
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The range of neurobehavioral alterations, however, 
depends on the intensity/dosage and duration of the factor 
in question as well as on the developmental stage of the 
brain. Chronic alcohol consumption during pregnancy 
results in fetal alcohol related abnormalities (FARA). Most 
serious manifestation of FARA is fetal alcohol syndrome 
(FAS). FAS is characterized by triads of pathological signs: 
prenatal and postnatal growth retardation, impairment of 
the CNS and facial deformities. On the other hand, mild 
social drinking in pregnancy causes mostly functional 
alterations of the brain, called alcohol related neurodevel-
opmental disorders (ARND) or fetal alcohol effect (FAE). 
FAE is characterized by verbal, cognitive and attention 
deficit (McGough et al., 2009; McGee et al., 2009). 
Fetal and neonatal brain development is characterized 
by developmental time windows during which certain 
brain regions or neuron types are specifically sensitive to 
environmental influences. The immature brain is much 
more sensitive to abnormal experience, particularly sleep 
deprivation, drug exposure, and maternal separation. 
The critical time period, during which features in brain 
susceptibility to such experience change, however, has 
not yet been fully determined. Basal forebrain cholinergic 
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Introversion, extroversion, mood, activity, adaptability, 
distractibility, persistence and attention span, as well as 
aggressiveness, social ability, tendency to depression and/
or anxiety do not need to be primarily innate. Individual 
characteristics of human nature and behavior could be 
determined by the action of various influences and their 
interactions on functional brain development. 
There is ample epidemiological and experimental evi-
dence that chemical and/or physical factors acting during 
sensitive time windows of the brain development can cause 
behavioral, emotional and/or cognitive dysfunctions. 
Environmental pollutants, addictive substances, drugs, 
malnutrition, excessive stress and/or hypoxia-ischemia 
were reported to induce functional maldevelopment of 
the brain with consequent neurobehavioral disorders. 
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neurons were found to be sensitive to nerve growth fac-
tor (NGF) deprivation during the first postnatal week 
not later (Molnar et al., 1997). The study of Feng et al. 
(2001) is an excellent example of sensitive developmental 
periods from the neurotoxicity point of view. Male rats 
neonatally treated with the tricyclic antidepressant clo-
mipramine (CLI) during various treatment windows, i.e. 
postnatal days (PD) 12–17, 14–20, 16–22, and 12–15, were 
in adulthood tested for sexual behavior. The rats treated 
with CLI showed significant sexual impairment in treat-
ment windows PD12–17 and PD14–20 and slight sexual 
deficiency in the short window PD12–15. No significant 
sexual impairment was found in window PD16–22. The 
results indicate that PD14–20 is the latest window during 
which CLI treatment can produce adult sexual deficiency 
and that 6 days might be the shortest treatment window 
to produce significant behavior abnormalities. 
Moreover, genetic disposition of the fetus, gender 
and racial differences may affect the action of individual 
factors and/or their interferences. Experimental neonatal 
stress and/or monosodium glutamate (MSG) treatment 
can be an example referring to gender issue. MSG and 
combined stressful stimuli represented by 10% NaCl 
administration and mild handling on PD 2, 4, 6, 8 and 10 
were found to increase locomotor activity and slow down 
habituation in an open field test in adult male but not 
female rats (Dubovický et al., 1997; 1999). 
Activity of enzyme alcohol-dehydrogenase metaboliz-
ing ethanol is different in Whites compared to Chinese, 
Native Americans and Japanese (Agarwal and Goedde, 
1986). In this respect it is possible that fetal susceptibility 
to alcohol may also be dependent upon maternal racial 
and genetic dispositions interacting with consumption 
patterns. The basis of these differences remains however 
to be elucidated. Among Blacks, slower metabolism of 
nicotine was found in comparison with Whites (Benowitz 
et al., 1999). Perera et al. (2004) found higher umbilical 
cord serum of the nicotine metabolite cotinine in Blacks 
versus Hispanic newborns. Racial differences in nicotine 
metabolism could reflect differences in low-level prenatal 
smoking on infant behavior. While among White infants, 
increased cotinine levels were associated with increased 
arousal and excitability and decreased self-regulation 
(ability to calm dawn), on the contrary, in Black infants 
increased cotinine levels were associated with decreased 
arousal and excitability and increased ability to self-
regulate (Yolton et al., 2009). 
The present article provides review on the most sig-
nificant neurobehavioral manifestations of developmen-
tal impairment of the brain during the prenatal, perinatal 
and early postnatal/neonatal period. The best known 
adverse factors causing neurodevelopmental behavioral 
dysfunctions in humans as well as in experimental ani-
mals with possible mechanisms of action are discussed. 
The classification of neurobehavioral disorders is not 
unequivocal. Individual manifestations of the disorders 
can overlap. Attention deficit-hyperactivity disorder 
(ADHD) generally belongs to the group of behavioral 
disorders. However, attention deficit as its part can be 
classified as a cognitive dysfunction and ADHD may be 
accompanied also by mood changes. To facilitate orienta-
tion in the broad spectrum of neurobehavioral disorders, 
the review is divided into four most important groups 
of disorders: serious neurodevelopmental disorders, 
cognitive disorders, mental disorders and emotional and 
behavioral disorders. 
Serious neurodevelopmental disorders
The majority of signs of serious neurodevelopmental 
disorders do not belong to the spectrum of neurobehav-
ioral dysfunctions. Although some of these disorders can 
be associated with neurobehavioral deficit or with an 
increased risk for behavioral alterations in later postnatal 
development. However, if cerebral palsy, neurological 
disorders, epilepsy and severe mental retardation were not 
mentioned, the survey of significant neurodevelopmental 
pathologies would be incomplete. 
Cerebral palsy describes a group of permanent 
disorders of the development of movement and posture, 
causing activity limitations attributed to nonprogressive 
disturbances occurring in the developing fetal or infant 
brain. The motor disorders of cerebral palsy are often 
accompanied by disturbances of sensation, perception, 
cognition, communication, and behavior, or by epilepsy 
and secondary musculoskeletal problems (Horsman et al., 
2010). While in certain cases there is no identifiable cause, 
other etiologies include problems in intrauterine develop-
ment (e.g. exposure to radiation, infection), hypoxia of 
the brain and birth trauma during labor and delivery, 
and complications in the perinatal period or during 
childhood (Brucknerová et al., 2008). After birth, other 
causes include toxins, severe jaundice, lead poisoning, 
physical brain injury, incidents involving hypoxia to 
the brain and encephalitis or meningitis (Mendola et al. 
2002; Gilbertson, 2004). 
A neurological disorder is a disorder of the body’s 
nervous system. Structural, biochemical or electrical 
abnormalities in the brain or spinal cord or in the nerves 
leading to or from them, can result in manifestations such 
as paralysis, muscle weakness, poor coordination, loss of 
sensation, seizures, confusion, pain and altered levels of 
consciousness. A unique example of neurological compli-
cations due to developmental effects of chemicals is the 
Minamata disease. The first well-documented outbreak 
of acute developmental methyl mercury poisoning by 
consumption of contaminated fish occurred in Minamata, 
Japan, in 1953. Typical features of the disease are as fol-
lows: sensory disturbances, ataxia, seizures, constriction 
of the visual field, auditory disturbances and tremor 
(Harada, 1995, Ekino et al., 2007). Fetal neurodevelop-
ment depends on cell programs, developmental trajecto-
ries, synaptic plasticity, and oligodendrocyte maturation, 
which are variously modifiable by factors such as stress 
and endocrine disruption, exposure to pesticides such 61
Also available online on intertox.sav.sk & versita.com/science/medicine/it
Interdisciplinary Toxicology. 2010; Vol. 3(2): 59–67
Copyright © 2010 Slovak Toxicology Society SETOX
as chlorpyrifos and to drugs such as terbutaline, and 
by premature birth (Mendola et al., 2002; Connors et al., 
2008). Prenatal nicotine was reported to cause abnormal 
reflexes and hypertony/hypotony in neonates and infants 
(Yolton et al., 2009). 
Epilepsy is a common chronic neurological disorder 
characterized by recurrent unprovoked seizures. These 
seizures are transient signs and/or symptoms of abnor-
mal, excessive or synchronous neuronal activity in the 
brain. Epilepsy is more likely to occur in young children 
or people over the age of 65 years, however it can occur at 
any time (Fisher et al., 2005). During the neonatal period 
and early infancy the most common causes of epilepsy 
include  hypoxic-ischemic encephalopathies, CNS 
infections, toxins, trauma, congenital CNS abnormali-
ties and metabolic disorders (Scher, 2003; Vestergaard 
et al., 2005). 
Mental retardation is a generalized disorder, charac-
terized by significantly impaired cognitive functioning 
and deficits in adaptive behavior with onset before the age 
of 18. It has historically been defined by an intelligence 
quotient score under 70. Once focused almost entirely 
on cognition, the definition now includes both a com-
ponent relating to mental functioning and one relating 
to the individual´s functional skills in the environment 
(Van der Aa et al., 2010). Down syndrome, fetal alcohol 
syndrome and fragile X syndrome are the three most 
common inborn causes of mental retardation. A woman 
who drinks alcohol or gets an infection like rubella dur-
ing pregnancy may also have a baby with mental disability 
(Batshaw, 1993; Devenny et al., 2000; Merrick et al., 2006). 
If a baby has problems during labor and birth, as e.g. not 
getting enough oxygen, he or she may have developmental 
disability due to brain damage (Kaindl et al., 2009).
Cognitive disorders
Cognitive disorders are disorders in which the central 
feature is impairment of memory, attention, perception, 
thinking, problem solving and language. 
Drinking of alcohol during pregnancy seriously affects 
neurobehavioral development of children. Even social 
drinking in pregnancy was found to result in cognitive 
dysfunctions accompanied by deficit in language ability in 
infants both in reception and expression of the language 
(McGee et al., 2009). Attention problems were found in 
children of mothers drinking in pregnancy and/or using 
psychotropic drugs (Dalen et al., 2009). 
Polybrominated diphenyl eters (PBDEs) are synthetic 
flame retardants added to polymers for the manufacture 
of electrical appliances, carpets and polyurethane foam. 
They have similar effects as polychlorinated biphenyls. 
They bind to androgen and estrogen receptors and can 
injure the activity of thyroidal hormones, which play 
a significant role in neurodevelopmental processes such 
as timing of neural and glial proliferation, migration 
and differentiation, myelination, synaptic connectivity, 
development of dopaminergic and cholinergic system 
(Figueredo et al., 1993; Sawin et al., 1998; Auso et al., 
2004;). The functional maldevelopment due to PBDs can 
lead to neurocognitive dysfunctions. A mixture of PBDs 
in the neonatal period was reported to result in cognitive 
deficit with disorders of attention and inhibitory control 
in rats (Driscoll et al., 2009). Rats exposed prenatally to 
polychlorinated biphenyls and/or methyl mercury had 
a deficit in cognitive and behavioral tests (Sable et al., 
2009). 
About 12% of women do not quit smoking during 
pregnancy. Nicotine causes intrauterine growth retar-
dation, increases the risk for miscarriage and cognitive 
and behavioral disorders. Nicotine mimics the action of 
acetylcholine which plays an important role in the devel-
opment of auditory neural circuitry. During development, 
excessive stimulation of nicotine receptors can lead to 
their injury. This in turn can result in injury of sensory 
encoding of auditory information associated with disorder 
of auditory habituation in neonates, delayed vocalization, 
disorders of language perception and reading abilities in 
infants (Kable et al., 2009). 
The Environment Protection Agency (USA) considers 
the blood level of 10 μg/dL lead to be a risk for health. 
Recent studies, however, showed that levels under 5 μg/dL 
can injure cognitive functions, lower the score of reading 
abilities and mathematics. Moreover, prenatal alcohol 
and/or drugs can increase sensitivity to lead toxicity in 
neonates and infants (Min et al., 2009). 
Prenatal cocaine acts adversely during development 
by two basic mechanisms: it decreases uterine blood flow 
resulting in fetal hypoxia, and it affects development of 
the brain monoamines leading to functional maldevelop-
ment of the brain mostly in the prefrontal cortex, which 
is responsible for executive functions, attention and neu-
rocognitive functions. Prenatal cocaine causes attention 
deficit and has negative effects on reaction of the organ-
ism to new stimuli (Hurt et al., 2009; Eiden et al., 2009). 
It is important to note that functional development of 
the brain does not end in infancy. Functional maturation 
of the brain continues to adolescence, e.g. processes of 
sprouting and pruning. Alcohol and addictive substances 
in adolescents can therefore have more deleterious effects 
than in adults. Binge drinking in adolescents was reported 
to cause macrostructural and microstructural changes 
of the white matter (e.g. volume, density of fibers, etc.) 
(Jacobus et al., 2009). These alterations in turn can lead 
to neurocognitive dysfunctions in later development or 
could potentate unfavorable effects of other environmen-
tal factors. 
Organophosphate pesticides damage replication of 
neurons, differentiation, axogenesis, synaptogenesis and 
development of neuronal circuitry. They affect ACh and 
5-HT systems, what in turn may lead to cognitive dys-
function as well as the emotional and behavioral disorders 
(Slotkin et al., 2009). 
Prenatal and/or perinatal hypoxia-ischemia is a major 
factor for the development of cognitive dysfunctions in 62
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later life (Gitto et al., 2009; Brucknerová et al., 2008; 
Mach et al., 2009). Memory and learning deficits are very 
frequent consequences of lack of oxygen and nutrition 
during brain development. The hippocampus is one brain 
region that can be damaged and this site of damage has 
been implicated in two different long-term outcomes, 
cognitive memory impairment and the psychiatric 
disorder schizophrenia (de Haan et al., 2006). The risk 
of cognitive deficits is related to the severity of neonatal 
encephalopathy and the pattern of brain injury on neu-
roimaging, particularly the watershed pattern of injury 
(Gonzales & Miller, 2006). Cognitive deficit is one of the 
manifestations of fetal hydantoin syndrome due to tera-
togenicity of phenytoin (PHT), an anticonvulsant drug 
used in treatment of epilepsy. PHT is considered to induce 
teratogenicity by affecting the hemodynamic status of the 
pregnant mother as well as of the embryo/fetus, eventu-
ally leading to embryo-fetal hypoxia (Adams et al., 1990; 
Wells and Winn, 1996; Navarová et al., 2005; Ujházy et 
al., 2008). PHT causes serious structural and functional 
changes including memory deficiency (Okruhlicová 
et al., 2003; Ujházy et al., 2004; Mach et al., 2005). 
Xenoestrogens were reported to negatively affect spatial 
learning of male rats in water maze (Ceccarelli et al., 2009).
Mental disorders 
A mental disorder is a psychological or behavioral pattern 
associated with distress or disability that occurs in an 
individual and is not a part of normal development or cul-
ture. The recognition and understanding of mental health 
conditions has changed over time and across cultures, and 
there are still variations in the definition, assessment, 
and classification of mental disorders, although standard 
guideline criteria have been widely accepted (American 
Psychiatric Association, 2000). Mental disorders can arise 
from a combination of sources. In many cases there is no 
single accepted or consistent cause currently established. 
A common belief even to this day is that disorders result 
from genetic vulnerabilities exposed to environmental 
stressors. 
Schizophrenia is a mental disorder characterized by 
abnormalities in the perception or expression of reality. It 
is most commonly manifested as auditory hallucinations, 
paranoid or bizarre delusions, or disorganized speech and 
thinking with significant social or occupational dysfunc-
tion. Onset of symptoms typically occurs in young adult-
hood, with around 0.4–0.6% of the population affected 
(Castle et al., 1991). 
There is much evidence of neurodevelopmental origin 
of schizophrenia. Epidemiological studies found a season-
ally-related increase in schizophrenia for people born in 
winter months when infections are more frequent (Battle 
et al., 1999). Reelin, a protein that regulates processes of 
neuronal migration and positioning in the developing 
brain, showed significantly reduced gene expression in 
the brain of schizophrenic patients as well as in animals 
used as a model of this disease (Erbel-Sieler et al., 2004). 
In schizophrenia, dopaminergic hyperfunction in certain 
brain regions is considered the key element of the disease. 
The developmental model of schizophrenia has been 
proposed based on the dopamine hypothesis. It has been 
shown that neonatal exposure to the dopamine D2/3 
receptor agonist quinpirole leads to supersensitivity or 
priming of D2/3 receptors (Kostrzewa, 1995; Kostrzewa 
et al., 2005). This supersensitivity was accompanied by 
spatial learning deficit and alterations in motor activity 
(Vorhees et al., 2009). 
Anxiety disorders are blanket terms covering several 
different forms of abnormal and pathological fear and 
anxiety. Current psychiatric diagnostic criteria recognize 
a wide variety of anxiety disorders: generalized anxiety 
disorder, panic disorder, phobias, social anxiety disorder, 
obsessive–compulsive disorder, post-traumatic stress dis-
order, separation anxiety, childhood anxiety disorder. The 
amygdala is central to the processing of fear and anxiety, 
and its function may be disrupted in anxiety disorders. 
There are many experimental studies confirming the 
relationship between prenatal/perinatal insults and adult 
anxiety disorders. Whereas in humans, more studies 
would be needed to ascertain long-term behavioral effects 
of adverse stimuli on pregnant women and their offspring. 
Emerging data from human and animal perinatal expo-
sure studies demonstrate a subtle effect of cannabis 
upon later brain functioning including specific cognitive 
deficits, especially in visuospatial function, impulsivity, 
inattention and hyperactivity, depressive/anxiety signs 
and symptoms (Sundram, 2006). Maternal exposure to 
caffeine was found to induce long-term consequences 
on sleep, locomotion, learning abilities, emotivity, and 
anxiety in rat offspring (Nehlig & Debry, 1994). 
Hypoxia-ischemia represents a risk factor for func-
tional alterations of the brain structures and functions 
related to anxiety/fear. Asphyxiated animals in the 
perinatal period were found to exhibit a significantly 
decreased social aggressiveness and an increased social 
contact behavior, as well as increased anxiety levels in 
adulthood (Weitzdoerfer et al., 2004). Antenatal inter-
mittent hypoxia caused a decrease of motor activity as 
well as an enhanced anxiety level in rats of both sexes, 
while males appeared to be more sensitive to hypoxic 
influence (Trofinmova et al., 2010). Other studies have 
also shown that neurobehavioral changes due to mild 
perinatal hypoxia were mainly related to emotional/anx-
ious responses (Hoeger et al., 2000; Venerosi et al., 2006). 
The neuroendocrine system, especially the hypo-
thalamus-pituitary-adrenal (HPA) axis, is very sensitive 
to  excessive stressful stimuli during development. 
Prenatal stress can interfere with functional development 
of the brain a can cause neurobehavioral dysfunctions 
in later postnatal period. Epidemiological studies pro-
vided knowledge on long-term effects of prenatal stress 
on neurobehavioral development (Graignic-Phillipe & 
Tordjman, 2009), cognitive ability and fearfulness in 
infancy (Bergman et al. ,  2007 ) .  Expe rim e n tal  stu di es  63
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showed that increased levels of stress hormones could 
affect development of hippocampus and other brain 
regions and cause long-term changes in HPA axis reac-
tivity (Sapolsky et al., 1984; Uno et al., 1990). Behavioral 
alterations were correlated with an increase of cortico-
streone level in reaction to a stressful stimulus, as well 
as its prolonged secretion, and a decreased density of 
hippocampus glucocorticoid receptors (Henry et al., 
1994; Maccari et al., 1995; Vallée et al., 1996; Maccari & 
Morley-Fletcher, 2007). Prenatal stress is associated with 
an increased anxiety/fear-like behavior in adult rats and 
an increased sensitivity of to stressful stimuli (Valleé et 
al., 1997). Repeated stress in late pregnancy in monkeys 
was found to induce depressive behavior in infant mon-
keys and cognitive deficit (Schneider, 1992). Prenatal 
social stress can program anxiety behavior and HPA axis 
responses to stress in offspring. Attenuated glucocorticoid 
feedback mechanisms in the limbic system may underlie 
HPA axis hyper-reactivity to stress in offspring (Brunton 
& Russel, 2010). Prenatal stress has been found to affect 
brain development and behavior of male and female rats 
differentially (Weinstock, 2007). On the other hand, early 
postnatal stress in the form of manipulation (handling) 
resulted in decreased anxiety and corticosterone secre-
tion in reaction to stressful stimuli (Valée et al., 1997). 
Altered behavior observed in adulthood is likely the result 
of neurodevelopmental perturbations elicited by early life 
stress. It can be assumed that there is "a critical period" 
for neural circuits involved in emotional expression that 
contribute to lifelong susceptibility to stress (Matsumoto 
et al., 2009). Moreover, developmental administration of 
some drugs can affect HPA axis functioning in adulthood. 
Exposure to phenytoin in utero was found to increase 
catecholamine and corticosterone concentrations in 
response to a mild stressor in adult offspring (Makatsori 
et al., 2005). 
Mood/affective disorders are characterized by a consis-
tent, pervasive alteration in mood, and affecting thoughts, 
emotions, and behaviors. There are two basic types of 
mood disorders, i.e. depressive and bipolar disorder. In 
affective disorders, we also need to rely on experimental 
studies. 
It was shown that prenatal exposure to the inhibitor 
of serotonin (5-HT) synthesis para-chlorophenylalanine 
(PCPA) caused fetal 5-HT depletion and change both in 
open field activity and in depression-related behavior in 
the adult rat offspring (Vataeva et al., 2008). Prescription 
of selective serotonin reuptake inhibitors and/or sero-
tonin-noradrenalin reuptake inhibitors (SSRI/SNRI) 
in pregnancy and lactation may represent a risk for the 
unborn child. Prenatal administration of fluoxetine in 
mice resulted in dose-dependent development of affective 
disorders (Noorlander et al., 2008). Prenatal exposure to 
fluoxetine caused a decrease in a number of neurons in the 
frontal cortex (Swerts et al., 2009) and decrease in 5-HT 
receptor density in the frontal cortex in pre-pubescent 
rats and in the middle brain in adult rats (Cabrera-Vera et 
al., 1997). Generally, administration of SSRI and/or SNRI 
drugs during sensitive developmental periods of the brain 
increases the risk for neuronal circuitry alterations and 
maladaptive behavior persisting up to adulthood in the 
form of enhanced depression and/or anxiety, and even 
aggressive behavior (Borue et al., 2007). 
Emotional and behavioral disorders
Emotional and behavioral disorders form a broad category, 
which is used commonly in educational settings, to group 
a range of more specific perceived difficulties of children 
and adolescents. Both general definitions as well as actual 
diagnosis of these disorders may be controversial as the 
observed behavior may depend on many factors.
Emotions and behavior are controlled by a complex 
of central executive and regulatory functions. Executive 
functions are a complex of cognitive and behavioral com-
petences inevitable in solving demanding, non-routine 
and aim-oriented tasks and/or situations. (organizational 
and information processing, oriented attention, work-
ing memory, inhibition). The emotional and behavioral 
regulatory system has two basic components. The first is 
the latency and intensity of reactions to environmental 
stimuli (reactivity), the second is represented by behav-
ioral responses and strategy/coping modulated by the 
reactions (regulatory components) involving self-calming, 
communicative behavior, behavioral strategy to disperse 
attention from the incentive stimulus and/or approach/
withdrawal behavior. Emotional arousal regulation 
provides excitatory/inhibitory balance, which protects 
central executive functions against excessive stimulation 
and helps to coordinate cortical systems. The dorsal and 
lateral prefrontal lobe, amygdala and other brain regions 
are responsible for these functions (Drevets and Raichle, 
1998; Avants et al., 2007). Prenatal cocaine inhibits re-
uptake of DA, NA and 5-HT on the presynaptic membrane 
and causes vasoconstriction followed by hypoxia. This 
can lead to long-term cognitive and neurodevelopmental 
consequences manifested in middle infancy, puberty or 
adolescence when there are increased demands, chal-
lenges and more complex cognitive processes are needed 
for educational, behavioral, social and executive functions. 
It has been shown that prenatal cocaine affects execu-
tive functions manifested by lowered inhibitory control 
of excessive verbal responses in children (Rose-Jacobs 
et al., 2009). Moreover, prenatal cocaine damages the 
prefrontal cortex and amygdale, which leads to cognitive 
and emotional dysfunctions manifested by memory and 
attention alterations (Li et al., 2009). Prenatal cocaine can 
affect these regulatory systems and results in attention 
disorder, frustration, impulsivity, disruptive behavior, 
low motor inhibition. In experimental animals prenatal 
cocaine resulted in stress-related freezing and aggressive 
behavior (Eiden et al., 2009). 
Autism spectrum disorders (ASD) are a spectrum 
of psychological conditions characterized by widespread 
abnormalities of social interactions and communication, 64
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as well as severely restricted interests and highly repeti-
tive behavior. Autism is a disorder of neural development 
characterized by impaired social interaction and commu-
nication, and by restricted and repetitive behavior. These 
signs all begin before a child is three years old. Autism 
affects information processing in the brain by altering 
nerve cell and synaptic connection and organization. The 
other two disorders are Asperger syndrome, where there 
are delays in cognitive development and language, and 
Pervasive developmental disorder. Childhood disintegra-
tive disorder, also known as Heller’s syndrome and Rett 
syndrome are very close to autistic spectrum disorders 
as to certain signs, such as impaired social interaction. 
ASD has a strong genetic basis, although the genet-
ics of autism are complex and it is unclear whether it is 
explained more by rare mutations with major effects, 
or by rare multigene interactions of common genetic 
variants. The arising complexity is due to interactions 
among multiple genes, the environment, and epigenetic 
factors which do not change DNA but are heritable and 
influence gene expression (Abrahams & Geschwind, 
2008; Buxbaum, 2009). Several lines of evidence point 
to synaptic dysfunction as a cause of autism. All known 
teratogens related to the risk of autism appear to act dur-
ing the first eight weeks from conception, and though 
this does not exclude the possibility that autism can be 
initiated or affected later, there is strong evidence that 
autism arises very early in development (Arndt et al., 
2005). 
An association between autism and prenatal tha-
lidomide was found in Sweden study of autistic poeple 
(Strömland et al., 1994; Strömland et al., 2002). Compared 
to the rate of autistic children in Sweden (approximately 
1/1000), there was a highly significant increase in tha-
lidomide victims, about 5%. Animal studies showed that 
maternal administration of thalidomide or valproic acid 
caused disruption of early serotonegic neuronal develop-
ment and neurobehavioral alterations in a manner that is, 
in part, consistent with human autism (Miyazaki et al., 
2005; Narita et al., 2010). Other factors that have been 
claimed to contribute to or exacerbate autism, include 
infectious disease, heavy metals, organophosphates, 
solvents, diesel exhaust, phthalates and phenols used 
in plastic products, pesticides, brominated flame 
retardants, alcohol, smoking, illicit drugs, vaccines, 
and prenatal stress (Newschaffer et al., 2007; Kinney et 
al., 2008). Moreover, a hyperserotonemia in pregnancy 
du to SSRI treatment might be one of the reasons of the 
increasing frequency of autism in the human popula-
tion (Hadjikhani, 2009). Today children are surrounded 
by thousands of synthetic chemicals. Two hundred of 
them are neurotoxic in adult humans, and 1000 more in 
laboratory models. Yet fewer than 20% of chemicals have 
been tested for neurodevelopmental toxicity. Prevalence, 
genetic, exposure, and pathophysiological evidence all 
suggest a role for environmental factors in the inception 
and lifelong modulation of ASD. Expanded research into 
environmental causation of autism is however needed 
(Herbert, 2010; Landrigan, 2010). 
Attention-Deficit Hyperactivity Disorder (ADHD) 
is a neurobehavioral developmental disorder. It is pri-
marily characterized by “the co-existence of attention 
problems and hyperactivity, with each behavior occurring 
infrequently alone” and symptoms starting before seven 
years of age. ADHD is the most commonly studied and 
diagnosed psychiatric disorder in children, affecting 
about 3% to 5% of children globally and diagnosed in 
about 2% to 16% of school aged children. It is a chronic 
disorder with 30% to 50% of individuals diagnosed in 
childhood continuing to have symptoms into adulthood. 
Adolescents and adults with ADHD tend to develop cop-
ing mechanisms to compensate for some or all of their 
impairments. A specific cause of ADHD is not known. 
There are, however, a number of factors that may contrib-
ute to ADHD. They include genetics, diet and social and 
physical environments. 
Adverse impacts of chronic or intermittent hypoxia 
on development, behavior, and academic achievement 
have been reported in many well-designed and controlled 
studies in humans (Bass et al., 2004). An experimental 
s t u d y  o n  r a t s  s h o w e d  t h a t  p e r i n a t a l  a s p h y x i a  ( n o n -
sophisticated caesarian section model used) on day 20 of 
gestation in duration of 20 min resulted in hyperactivity 
in repeated open field test. However, the hyperactivity 
manifested gradually during the experiment. In the first 
session, the rats exhibited lower activity compared to con-
trols, indicating their neophobia in a new environment. 
This behavioral pattern resembled hyperactive profile 
in ADHD children. They are behaviorally inhibited in 
an unknown environment and highly active in familiar 
surroundings (Dubovicky et al., 2007; 2008). Global 
brain injury produced by neonatal hypoxia also produced 
hyperactivity, as did hippocampal injury produced by 
ontogenetic exposure to X-rays, and cerebellar injury 
produced by the developmental treatments with the 
antimitotic agent methylazoxymethanol or with poly-
chlorinated biphenyls (Sable et al., 2009). More recently, 
developmental exposure to nicotine has been implicated 
in childhood hyperactivity (Kostrzewa et al., 2008; Kable 
et al., 2009). 
Conclusion
Maintenance of the optimal fetal environment is the 
key factor of the future quality of life. Conditions like 
inadequate nutrition and oxygen supply, infection, hyper-
tension, gestational diabetes or drug abuse by the mother, 
expose the fetus to a non-physiological environment. In 
conditions of severe intrauterine deprivation, there is a 
potential loss of structural units within the developing 
organ systems affecting their functionality and efficiency. 
Extensive human epidemiologic and animal model data 
i n d i c a t e  t h a t  d u r i n g  c r i t i c a l  p e r i o d s  o f  p r e n a t a l  a n d  
postnatal mammalian development, nutrition and other 
environmental stimuli influence developmental pathways 
and thereby induce permanent changes in metabolism 
and chronic disease susceptibility (Bezek et al., 2008). 65
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There is epidemiological and experimental evidence 
that environmental factors influence a diverse array of 
molecular mechanisms and consequently alter disease 
risk not only for metabolic syndrome and cardiovascular 
diseases, insulin resistance and diabetes mellitus, osteo-
porosis, asthma and immune system diseases but also for 
psychiatric and neurobehavioral disorders (Rinaudo & 
Lamb, 2008; Bezek et al., 2008). 
Fetal and early childhood exposures to industrial 
chemicals in the environment can damage the developing 
brain and can lead to neurodevelopmental disorders, such 
as autism, ADHD and mental retardation. We can speak 
of "a silent pandemic". As it was mentioned in the editorial 
in the Nature (2010), the beginning of the 21st century is 
becoming a decade for psychiatric disorders. Mental dis-
orders affect more than 27% of adult Europeans every year. 
They are the main cause of suicides in European Union. 
Economic issue of mental and behavioral disorders is also 
inconsiderable, treatment of these disorders can cost up 
to 4% of GDP (Krištofičová, 2008). Researchers have found 
that about 200 industrial chemicals have the capacity to 
damage the human brain, and they conclude that chemi-
cal pollution may have harmed the brains of millions of 
children worldwide (Labie, 2007). Nevertheless, the toxic 
effects of industrial chemicals on children have generally 
been overlooked. 
Further knowledge on possible unfavorable effects of 
chemical compounds as well as other harmful factors on 
the developing brain is needed. Serious epidemiological 
studies along with experiments by using appropriate 
animal models can help to elucidate possible risks for the 
developing organism and may decrease the frequency 
of mental and neurobehavioral disorders in the human 
population. 
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